Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Martin holds a PhD in Molecular Biology. After completing postdoctoral training he transitioned to the biotechnology industry where he has worked at companies including Immunex, Amgen, Wyeth and Pfizer. Martin is currently the Sr. Director for Cell Line Development at Pfizer, where he leads a multi-site organization dedicated to all aspects of cell line development to deliver Pfizer’s biotherapeutics and vaccines portfolio.
Rapid Development of Cell Lines Suitable for Commercial Manufacturing
Cell line development to support early phase clinical programs is often performed on rapid timelines, recognizing that it may be necessary to develop a new cell line to support commercialization if the programs advances to that stage. This presentation will focus on technologies and strategies that enable the most rapid development of an early phase cell line that is also suitable for commercial manufacturing (single cycle cell line development).